Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability

Haematologica

Volumn 88, Issue 5, 2003, Pages 547-554

  Chantarangkul, Veena ^a   Clerici, Marigrazia ^a   Bressi, Caterina ^a   Giesen, Peter L A ^b   Tripodi, Armando ^a,c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Synapse BV   (Netherlands)

^c NONE   (Italy)

Author keywords

Hypercoagulability; Hypocoagulability; Thrombin generation; Thrombin potential

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID; THROMBIN; THROMBOPLASTIN;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD FILTRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HEMOPHILIA; HUMAN; HYPERCOAGULABILITY; NORMAL HUMAN; PLASMA; PREMENOPAUSE; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD PLATELETS; CONTRACEPTIVES, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREEZING; HEMOPHILIA A; HUMANS; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; THROMBIN; THROMBOPHILIA; THROMBOPLASTIN;

EID: 0038777381     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Macfarlane RG, Biggs R. A thrombin generation test. J Clin Pathol 1953;6:3-7.
2. Pitney WR, Dacie J. A simple method of studying the generation of thrombin in recalcified plasma. J Clin Pathol 1953; 6:9-13.
3. Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986;56:9-17.
4. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993;70:617-24.
5. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Beguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000;83:589-91.
6. Wielders S, Mukherjee M, Michiels J, Rijkers DT, Cambus JP, Knebel RW, et al. The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypo-coagulability. Thromb Haemost 1997;77: 629-36.
7. Rotteveel RC, Roozendaal KJ, Eijsman L, Hemker HC. The influence of oral contraceptiyes on the time-integral of thrombin generation (thrombin potential). Thromb Haemost 1993;70:959-62.
8. Rosing J, Tans G, Nicolaes GA, Thomassen MC, Van Oerle R, van der Ploeg PM, et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol 1997;97:233-8.
9. Kyrle PA, Mannhalter C, Beguin S, Stumpflen A, Hirschl M, Weltermann A, et al. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol 1998;18:1287-91.
10. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002;88:576-82.
11. Keularts IMLW, Zivelin A, Seligsohn U, Hemker HC, Beguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 2001; 85:1060-5.
12. Tripodi A, Valsecchi C, Chantarangkul V, Battaglioli T, Mannucci PM. Standardization of activated protein C resistance testing: effect of residual platelets in frozen plasmas assessed by commercial and home-made methods. Br J Haematol 2003;120:825-8.
13. Hemker HC, Beguin S. Phenotyping the clotting system. Thromb Haemost 2000;84:747-51.